T-group (topology)
309.1.1 LuxS/MPP-like metallohydrolase
Ligands and drugs
3,232
Member domains
651
with ligand contacts (≤ 4 Å)
20.1% of members
645
with DrugDomain annotations
20.0% of members
322
with a DrugBank compound
10.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 309.1.1 belongs to X-group 309 LuxS, MPP, ThrRS/AlaRS common domain, which binds 6.7 ligand superclasses per 20 proteins, narrower than 64% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03429 | CDL | Tetrastearoyl cardiolipin | 78 |
| DB04327 | PEE | Phosphatidylethanolamine | 41 |
| DB09114 | PCF | Colfosceril palmitate | 31 |
| DB02686 | UMQ | Undecyl-Beta-D-Maltopyranoside | 14 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 12 |
| DB00134 | MET | Methionine | 8 |
| DB00626 | — | — | 4 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 4 |
| DB04799 | — | 6-Hydroxy-5-undecyl-4,7-benzothiazoledione | 4 |
| DB07401 | — | Azoxystrobin | 4 |
| DB07763 | — | (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | 4 |
| DB07778 | — | (S)-famoxadone | 4 |
| DB08330 | — | METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE | 4 |
| DB08453 | — | 2-Nonyl-4-quinolinol 1-oxide | 4 |
| DB08690 | — | Ubiquinone Q2 | 4 |
| DB00171 | ATP | ATP | 3 |
| DB00608 | CLQ | Chloroquine | 2 |
| DB01677 | FUM | Fumaric acid | 2 |
| DB03988 | LYN | 2,6-Diamino-Hexanoic Acid Amide | 2 |
| DB04346 | PAV | (2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 185 |
| CDL | CARDIOLIPIN | 147 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 94 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 52 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 38 |
| XP4 | 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHATE | 36 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 27 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 23 |
| PCF | 1,2-DIACYL-SN-GLYCERO-3-PHOSHOCHOLINE | 21 |
| UNL | Unknown ligand | 20 |
| 6PH | (1R)-2-(phosphonooxy)-1-[(tridecanoyloxy)methyl]ethyl pentadecanoate | 17 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 14 |
| CL | CHLORIDE ION | 13 |
| I41 | 2-[[2-[[(2S)-3-(3H-IMIDAZOL-4-YL)-1-METHOXY-1-OXO-PROPAN-2-YL]AMINO]-2-OXO-ETHYL]-(PHENYLMETHYL)AMINO]ETHANOIC ACID | 11 |
| 6PE | 1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE | 10 |
| PX4 | 1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 9 |
| J22 | {(8R,9S,10S)-9-(2',3'-dimethyl[1,1'-biphenyl]-4-yl)-6-[(1-methyl-1H-imidazol-2-yl)sulfonyl]-1,6-diazabicyclo[6.2.0]decan-10-yl}methanol | 8 |
| MET | METHIONINE | 8 |
| UMQ | UNDECYL-MALTOSIDE | 7 |
| 2Q6 | methyl [(2S)-2-[4-({5-[4-({(2S)-2-[(3S)-3-amino-2-oxopiperidin-1-yl]-2-cyclohexylacetyl}amino)phenyl]pentyl}oxy)phenyl]-3-(quinolin-3-yl)propyl]carbamate | 6 |